arrow
返回

Complement in autoimmune diseases

delete2017-02-01
delete105
PRE
AI
P
Pandiarajan Vignesh
A
Amit Rawat *
S
Surjit Singh
DOI:10.1016/j.cca.2016.12.017delete
delete原文链接
delete原文求助
delete分享
delete收藏
摘要

摘要

En 中文
The complement system is an ancient and evolutionary conserved element of the innate immune mechanism. It comprises of more than 20 serum proteins most of which are synthesized in the liver. These proteins are synthesized as inactive precursor proteins which are activated by appropriate stimuli. The activated forms of these proteins act as proteases and cleave other components successively in amplification pathways leading to exponential generation of final effectors. Three major pathways of complement pathways have been described, namely the classical, alternative and lectin pathways which are activated by different stimuli. However, all the 3 pathways converge on Complement C3. Cleavage of C3 and C5 successively leads to the production of the membrane attack complex which is final common effector. Excessive and uncontrolled activation of the complement has been implicated in the host of autoimmune diseases. But the complement has also been bemusedly described as the proverbial double edged sword. On one hand, complement is the final effector of tissue injury in autoimmune diseases and on the other, deficiencies of some components of the complement can result in autoimmune diseases. Currently available tools such as enzyme based immunoassays for functional assessment of complement pathways, flow cytometry, next generation sequencing and proteomics-based approaches provide an exciting opportunity to study this ancient yet mysterious element of innate immunity. (C) 2017 Elsevier B.V. All rights reserved.
Keyword:
Complement
Autoimmunity
Classical pathway
Altemative pathway
Systemic lupus erythematosus
Henoch Schonlein purpura
Antiphospholipid syndrome
ANCA-associated vasculitides
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Clinica Chimica Acta 封面图
Clinica Chimica Acta
IF:
2.9
论文数:
1.6W
被引数:
2.1W

机构

引用论文

引用论文

Complement C3 activation is required for antiphospholipid antibody-induced fetal loss
err2002-01-22
err475
errOAAI
errHolers, VM; Girardi, G; Mo, L; Guthridge, JM; Molina, H; Pierangeli, SS; Espinola, R; Xiaowei, LE; Mao, DL; Vialpando, CG; Salmon, JE
err分享
err收藏
67 Eukaryotic Heme Trafficking
err2012-07-01
err0
PREAI
errScott Severance; Caiyong Chen; Iqbal Hamza
err分享
err收藏
Case Report: Sustained Efficacy of Lumasiran at 18 Months in Primary Hyperoxaluria Type 1
err2022-01-05
err0
errOAAI
errBenedetta Chiodini; Nathalie Tram; Brigitte Adams; Elise Hennaut; Ksenija Lolin; Khalid Ismaili
err分享
err收藏
Meningococcal disease and the complement system
err2013-10-08
err165
errOAAI
errLewis, Lisa A.; Ram, Sanjay
err分享
err收藏
A critical role for complement in maintenance of self-tolerance
errIMMUNITY
IF26.3
err1998-11-01
err315
errOAAI
errProdeus, AP; Goerg, S; Shen, LM; Pozdnyakova, OO; Chu, L; Alicot, EM; Goodnow, CC; Carroll, MC
err分享
err收藏
Complement in acute and chronic arthritides: Assessment of C3c, C9, and protectin (CD59) in synovial membrane
err1996-12-01
err83
errOAAI
errKonttinen, YT; Ceponis, A; Meri, S; Vuorikoski, A; Kortekangas, P; Sorsa, T; Sukura, A; Santavirta, S
err分享
err收藏
Complement deficiencies and systemic lupus erythematosus
err2009-07-07
err250
PREAI
errTruedsson, Lennart; Bengtsson, Anders A.; Sturfelt, Gunnar
err分享
err收藏
Unique Phenotypes of C1s Deficiency and Abnormality Caused by Two Compound Heterozygosities in a Japanese Family
err2009-02-01
err14
errOAAI
errAbe, Katsuaki; Endo, Yuichi; Nakazawa, Naomi; Kanno, Kazuko; Okubo, Mitsuo; Hoshino, Tadashi; Fujita, Teizo
err分享
err收藏
学者 查看更多内容